SURMODICS INCSRDX

Market cap

$614.58M

P/E ratio

	Sep 30, 2011	Sep 30, 2012	Sep 30, 2013	Sep 30, 2014	Sep 30, 2015	Sep 30, 2016	Sep 30, 2017	Sep 30, 2018	Sep 30, 2019	Sep 30, 2020	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024
Product	-	-	-	-	-	-	-	-	40	44	46	55	61	74
Royalties	-	-	-	-	-	-	-	35	48	41	47	36	62	42
Research Development And Other	-	-	-	-	-	-	-	-	11	10	12	9	10	10
Total revenue	-	-	-	-	-	-	-	-	100	95	105	100	133	126
Product costs	-	-	-	-	-	-	-	14	14	15	17	20	25	33
Research and development	-	-	-	-	-	-	-	-	53	50	47	51	47	38
Selling, general and administrative	21	14	14	15	16	18	20	24	24	28	31	47	52	57
Acquired intangible asset amortization	-	-	-	-	-	2	2	2	2	2	3	4	4	4
Restructuring expense	2	-	0	-	-	-	-	-	-	-	-	-	1	-
Contingent Consideration Expense Gain	-	-	-	-	-	-	-	1	-0	-	0	0	-1	-
Total operating costs and expenses	85	36	37	39	43	55	66	90	94	96	98	122	127	132
Operating (loss) income	-18	16	19	19	19	17	7	-9	6	-1	7	-22	5	-6
Interest expense, net	-	-	-	-	-	-	-	-	-	-	-	-	-	4
Foreign exchange (loss) gain	-	-	-	-	-	-0	-1	0	0	-0	-0	0	-0	-0
Investment income, net	-	-	-	0	0	0	0	1	1	1	0	0	1	2
Other expense, net	1	-0	2	-0	-1	0	-0	1	1	-0	-0	-0	-3	-2
(Loss) income before income taxes	-	-	-	-	18	17	7	-8	8	-1	6	-22	2	-8
Income tax expense	-4	6	6	6	6	7	3	-3	-0	-3	2	5	4	4
Net loss	-13	10	15	12	12	10	4	-4	8	1	4	-27	-2	-12
Basic net loss per share	-0.73	0.59	1.05	0.88	0.92	0.77	0.3	-0.34	0.57	0.08	0.31	-1.96	-0.11	-0.82
Diluted net loss per share	-0.73	0.59	1.03	0.87	0.9	0.76	0.29	-0.34	0.55	0.08	0.3	-1.96	-0.11	-0.82